Boston, MA, United States of America

Michael Beauregard

USPTO Granted Patents = 2 


Average Co-Inventor Count = 10.2

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Beauregard: Innovator in Particle Technology

Introduction

Michael Beauregard is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of particle technology, holding 2 patents that showcase his innovative approach to particle conditioning and therapeutic applications.

Latest Patents

His latest patents include "Apparatuses and methods for formation of particles," which describes apparatuses and methods for conditioning particles. These methods are designed for first-in-first-out transit of particles through a chamber containing a conditioning fluid. This innovation enables the manufacture of particle preparations with consistent and improved properties compared to manual processes. Another patent, "Implantable particles and related methods," details particles that comprise a first compartment, a second compartment, and a compound of Formula (I). These particles may include a cell capable of expressing a therapeutic agent useful for treating various diseases, disorders, or conditions.

Career Highlights

Michael Beauregard is currently associated with Sigilon Therapeutics, Inc., where he applies his expertise in particle technology to advance therapeutic solutions. His work focuses on developing innovative methods that enhance the efficacy of particle-based treatments.

Collaborations

He collaborates with talented individuals such as Erika Ellen Johnston and Robert James Miller, contributing to a dynamic research environment that fosters innovation.

Conclusion

Michael Beauregard's contributions to particle technology through his patents and work at Sigilon Therapeutics, Inc. highlight his role as a leading inventor in this field. His innovative approaches continue to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…